HDIM
AGN

Hanson & Doremus Investment Management’s Allergan Inc AGN Stock Holding History

Hanson & Doremus Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-39
Closed -$12K – 495
2015
Q4 		$12K Buy
+39
New +$12K 0.01% 380

Other funds holding AGN

SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
CK
Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
AGA
Accuvest Global Advisors Provo, Utah $107M AUM 6.41% 1-Year Est. Return
LCM
Liberty Capital Management Birmingham, Michigan $582M AUM

Hanson & Doremus Investment Management's AGN Position: Q1 2016 in Review

Hanson & Doremus Investment Management sold out of Allergan Inc (AGN) in Q1 2016, closing a stake of 39 shares — an estimated $12K sold.

Hanson & Doremus Investment Management first reported a position in AGN in Q4 2015 and held it in 1 quarter. The position peaked at $12K in Q4 2015. 23 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Hanson & Doremus Investment Management reported no remaining Allergan Inc position as of Q1 2016 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 39 Allergan Inc shares in Q1 2016, an estimated $12K.
  • Hanson & Doremus Investment Management first reported a position in Allergan Inc in Q4 2015 and held it in 1 quarter.
  • Hanson & Doremus Investment Management's Allergan Inc position peaked at $12K in Q4 2015.
  • 23 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2016.

Based on Hanson & Doremus Investment Management's 13F filing for Q1 2016, filed 12 May 2016.